Bayer (BAYZF) said an experimental imaging agent accurately identified cardiac amyloidosis in a Phase 3 study, producing ...
EverythingLubbock.com on MSN
Covenant Medical unveils region’s first cardiac PET-CT scanner
Note: The above video shows the top headlines from the morning of September 2, 2025. LUBBOCK, Texas— Covenant Medical Group ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The Phase 3 REVEAL study met its primary endpoints, demonstrating sensitivity of 90%-94% and specificity of 84%-89% for diagnosing cardiac amyloidosis based on visual interpretation of scans by three ...
Based on the clinical and scientific evidence now available, there are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded.” — Timothy Bateman, ...
A newly developed cardiac PET imaging technique offers a simpler way to detect significant coronary artery disease—eliminating the need for complex scanning protocols. This innovative approach, which ...
MONTREAL--(BUSINESS WIRE)--Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an exclusive partnership with Cardiac Imaging, Inc.
A new radioactive tracer for positron emission tomography (PET) myocardial perfusion imaging will soon be available in the United States, and it’s expected to facilitate substantial growth in such ...
Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT ...
GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results